Medtronic launches stent delivery system in Canada
This article was originally published in Clinica
Medtronic's Captivia delivery system is now available in Canada. The device delivers the Valiant thoracic stent graft, a minimally-invasive treatment for aneurysms and other lesions of the thoracic aorta. Captivia was approved by Health Canada on 3 August. The Minneapolis, Minnesota firm also CE marked the device for sale in Europe in October 2009 (www.clinica.co.uk, 9 October 2009). Both the Captivia system and the Valiant graft are investigational in the US, with their use limited to clinical trials.